Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene therapy
gene therapy
Thermo Fisher to manufacture gene therapies being developed by Amicus
Fierce Pharma
Mon, 07/1/19 - 07:38 pm
Thermofisher
Amicus Therapeutics
gene therapy
CDMOs
3 Small-Cap Biotech Stocks That Soared Last Week
Motley Fool
Mon, 07/1/19 - 10:27 am
Dova Pharmaceuticals
Doptelet
Krystal Biotech
KB103
MeiraGTx
gene therapy
AAV-RPE65
Pfizer's DMD Gene Therapy Shows Severe Side Effects in Study
Yahoo/Zacks.com
Mon, 07/1/19 - 10:16 am
Pfizer
DMD
Duchenne Muscular Dystrophy
clinical trials
gene therapy
PF-06939926
Krystal looks to Phase III as stock soars on data for gene therapy
BioCentury
Tue, 06/25/19 - 09:15 am
Krystal Biotech
gene therapy
KB103
Pharmacquired: Is $11B enough to secure Sanofi's spot in hemophilia?
Biopharma Dive
Thu, 06/20/19 - 10:04 am
Sanofi
M&A
Bioverativ
hemophilia
gene therapy
Sanofi to ax 466 jobs, step up focus on cancer, gene therapy R&D
Fierce Biotech
Thu, 06/20/19 - 09:56 am
Sanofi
layoffs
Germany
France
R&D
immuno-oncology
gene therapy
'It's a growth play': Catalent acquires Bristol-Myers' European launch pad, expanding global CDMO ops
Endpoints
Wed, 06/19/19 - 10:29 am
Catalent
Europe
Bristol-Myers Squibb
Italy
gene therapy
CDMOs
What Bluebird Bio Gets Wrong In Pricing For Its $1.8 Million Drug
Forbes
Wed, 06/19/19 - 09:55 am
Bluebird Bio
gene therapy
drug pricing
Zynteglo
beta thalassemia
Rocket begins patient dosing in phase 1 trial of RP-A501 in Danon disease
Pharmaceutical Business Review
Wed, 06/19/19 - 09:52 am
Rocket Pharmaceuticals
gene therapy
Danon disease
RP-A501
Bluebird delays gene therapy launch to 2020, citing manufacturing tweaks
Biopharma Dive
Tue, 06/18/19 - 11:57 am
Bluebird Bio
gene therapy
drug manufacturing
Zynteglo
Sanofi Genzyme deserts gene therapy developer Voyager Therapeutics
Endpoints
Mon, 06/17/19 - 11:26 pm
Sanofi Genzyme
Voyager Therapeutics
gene therapy
bluebird offers installment payments for Zynteglo gene therapy
Pharmaforum
Mon, 06/17/19 - 12:25 pm
Bluebird Bio
outcome-based pricing
drug pricing
gene therapy
Zynteglo
beta thalassemia
Cue the M&A chatter: UniQure is scouting for a buyout deal as gene therapy field sizzles — report
Endpoints
Sun, 06/16/19 - 11:19 pm
uniQure
M&A
gene therapy
Gene therapy costs, manufacturing keeping CBER head 'up at night'
Biopharma Dive
Thu, 06/13/19 - 09:47 pm
gene therapy
CBER
drug manufacturing
The gene therapy era has arrived. So have the challenges.
Biopharma Dive
Sun, 06/9/19 - 01:43 pm
cell therapy
gene therapy
FDA
regulatory
Novartis
Zolgensma
Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy?
Motley Fool
Sun, 06/9/19 - 01:41 pm
gene editing
gene therapy
DMD
Duchenne Muscular Dystrophy
Vertex Pharmaceuticals
CRISPR Therapeutics
Exonics
Vertex sets sights on DMD gene therapy, joining crowded field
Biopharma Dive
Fri, 06/7/19 - 10:17 am
Vertex Pharmaceuticals
DMD
M&A
CRISPR Therapeutics
Exonics
gene therapy
Patients, payers await pricing plans for bluebird's first approved gene therapy
BioCentury
Tue, 06/4/19 - 11:04 am
Bluebird Bio
gene therapy
Zynteglo
drug pricing
beta thalassemia
Bluebird Bio’s Gene Therapy for Blood Disease Wins European Approval
Xconomy
Mon, 06/3/19 - 07:50 pm
Bluebird Bio
gene therapy
Europe
Zynteglo
EMA
beta thalassemia
Is the $2.1 Million Price Tag for Novartis' Zolgensma Ridiculous?
Motley Fool
Fri, 05/31/19 - 11:53 pm
Novartis
Zolgensma
SMA
gene therapy
Pages
« first
‹ previous
…
26
27
28
29
30
31
32
33
34
…
next ›
last »